Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
641 Leser
Artikel bewerten:
(2)

RHÖN-KLINIKUM Aktiengesellschaft: Partnership with Asklepios Strengthens Medical Care at the University Hospitals in Giessen and Marburg

DJ RHÖN-KLINIKUM Aktiengesellschaft: Partnership with Asklepios Strengthens Medical Care at the University Hospitals in Giessen and Marburg

DGAP-Media / 2020-09-07 / 12:59 
 
*Press Release* 
 
Bad Neustadt / Saale | 7th September 2020 
 
*RHÖN-KLINIKUM AG: Partnership with Asklepios Strengthens Medical Care 
at the University Hospitals in Giessen and Marburg* 
 
22 new specialist nurses with experience in intensive care, neonatology, 
cardiology and surgery who have transferred from the Asklepios Group will 
start work in the university hospital in Giessen today. The university 
hospital is thus able to benefit for the first time from newly provided 
access to a variety of Asklepios training programmes. The 19 new female 
employees and three male employees originate from the Philippines. They have 
all been awarded a Bachelor degree and are certified in medical and 
healthcare, seven of them also have widespread experience in intensive 
cardiological medical care. 
 
*Personnel Situation Strengthened for the Long-Term* 
 
RHÖN-KLINIKUM AG and Asklepios plan to intensify the partnership in 
personnel matters and training measures in the coming months. A further 60 
nurses will transfer from Asklepios to the university hospitals in Giessen 
and Marburg (UKGM) by the end of this year. Dr. Gunther K. Weiss, UKGM CEO 
and Board Member of RHÖN-KLINIKUM AG, stated: "The lack of specialist 
staff is also becoming more and more evident at UKGM. Not least because the 
minimum level of staff which the state has prescribed will take effect in a 
stronger manner next year. The cooperation with Asklepios is a good addition 
to our various initiatives to employ new nurses in our hospitals." 
 
Dr. Christian Höftberger, Board Member of RHÖN-KLINIKUM AG, commented 
on the new partnership with Asklepios: "The 22 new specialist nurses who 
have transferred from Asklepios to UKGM are only the beginning of our 
intensive cooperation in the areas of nursing and training. Together we 
shall strengthen the personnel situation at UKGM for the long-term, further 
improve patient care and reduce the work burden on our employees." 
 
*Employees with Good Qualifications for German Hospitals* 
 
Asklepios has been taking on international nursing staff since 2017 in order 
to offset the lack of specialist staff in Germany. Asklepios now employs 
almost 500 international nurses in its German hospitals, mainly as qualified 
intensive-care specialists. The new employees at UKGM attended the Asklepios 
training centre for international nurses in Darmstadt to prepare for their 
work in Giessen and passed the required theoretical examinations there. The 
Asklepios training programme included an intensive German language course at 
B2 level and an intensive workshop on nursing in Germany which lasted for a 
number of weeks. 
 
Apart from its many own training courses RHÖN-KLINIKUM AG also launched 
a programme for hiring international specialist staff just over ten years 
ago. It was especially developed to include language skills and specific 
theoretical and practical principles of hospital processes in Germany. The 
first course to attract international physicians to the RHÖN-KLINIKUM 
campus in Bad Neustadt was the scholarship programme for physicians. Such 
measures enable RHÖN-KLINIKUM AG to make an important contribution to 
ensuring good medical care even in rural areas. 
 
=- 
 
*RHÖN-KLINIKUM AG* is one of the largest healthcare providers in 
Germany. The hospital group offers excellent medical care with a direct link 
to universities and research institutes. Over 860,000 patients are treated 
every year at the five group hospitals located in Bad Berka, Bad Neustadt, 
Frankfurt (Oder), Giessen and Marburg where more than 18,000 employees work. 
RHÖN-KLINIKUM AG is currently exploiting the opportunities available to 
develop new areas of growth. Entering the leading-edge telemedicine market 
with Medgate Deutschland, the innovative RHÖN campus concept for 
offering forward-looking healthcare across sectoral boundaries in rural 
areas as well as consistently extending our gradual corporate digitalisation 
are key pillars of the corporate strategy. 
 
More information under www.rhoen-klinikum-ag.com [1] 
 
*Follow us:* 
 
www.twitter.com/rhoenklinikumag [2] 
www.xing.com/companies/rhön-klinikumag [3] 
www.youtube.com/rhönklinikumag [4] 
 
*RHÖN Healthcare Blog:* 
 
https://www.rhoen-gesundheitsblog.de/ [5] 
 
*Contact Persons:* 
 
RHÖN-KLINIKUM AG | Head of Corporate Communications and Marketing 
Elke Pfeifer 
Telephone: +49 9771 65-12110 | E-Mail: elke.pfeifer@rhoen-klinikum-ag.com 
 
RHÖN-KLINIKUM AG | Head of Investor Relations and Treasury 
Julian Schmitt 
Telephone: +49 9771 65-12250 | E-Mail: julian.schmitt@rhoen-klinikum-ag.com 
 
RHÖN-KLINIKUM AG | Schlossplatz 1 | 97616 Bad Neustadt / Saale, Germany 
 
End of Media Release 
 
Issuer: RHÖN-KLINIKUM Aktiengesellschaft 
Key word(s): Health 
 
2020-09-07 Dissemination of a Press Release, transmitted by DGAP - a service 
of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
The DGAP Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
Language:    English 
Company:     RHÖN-KLINIKUM Aktiengesellschaft 
             Salzburger Leite 1 
             97616 Bad Neustadt a.d.Saale 
             Germany 
Phone:       +49 (0)9771 - 65-0 
Fax:         +49 (0)9771 - 97 467 
E-mail:      rka@rhoen-klinikum-ag.com 
Internet:    www.rhoen-klinikum-ag.com 
ISIN:        DE0007042301 
WKN:         704230 
Listed:      Regulated Market in Frankfurt (Prime Standard), Munich; 
             Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, 
             Hanover, Stuttgart, Tradegate Exchange 
EQS News ID: 1128225 
 
End of News DGAP Media 
 
1128225 2020-09-07 
 
 
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=7491acecb3a7b48b50428efb792075af&application_id=1128225&site_id=vwd&application_name=news 
2: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=11ea30633d70c18742d7158e5d9c810f&application_id=1128225&site_id=vwd&application_name=news 
3: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=eb3a1db0347b04bde73f99da807a9f7d&application_id=1128225&site_id=vwd&application_name=news 
4: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=e7771a5f41b6530d2ed676a14f9ab2a3&application_id=1128225&site_id=vwd&application_name=news 
5: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=6dbfeb7f6104b24df2e90c865ac8e2b8&application_id=1128225&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

September 07, 2020 06:59 ET (10:59 GMT)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.